Citigroup raises target for Johnson & Johnson stock
Published on 10/06/2026 at 13:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Johnson & Johnson (ISIN US4781601046) was trading at EUR 226.08 at Lang & Schwarz on October 6, 2026 at 1:02 p.m. CEST, up 0.31 percent versus the prior close of EUR 225.38. On October 5, 2026, Citigroup maintained its Buy rating and raised its price target from USD 298.00 to USD 303.00, as reported by GuruFocus.
Second-quarter growth supports guidance
Johnson & Johnson reported USD 25.3 billion in sales in the second quarter of 2026, up 6.6 percent from the year-earlier quarter. Adjusted earnings per share reached USD 2.90 versus a USD 2.84 consensus estimate, according to The Globe and Mail.
The same second-quarter report showed a split performance across the business. Innovative Medicine sales rose 7.8 percent to USD 16.38 billion, while MedTech sales increased 4.5 percent to USD 8.93 billion but came in below the USD 8.96 billion consensus estimate. Johnson & Johnson also lifted 2026 reported sales guidance to USD 100.8 billion-USD 101.4 billion from USD 100.3 billion-USD 101.3 billion, and adjusted earnings per share guidance to USD 11.60-USD 11.75 from USD 11.45-USD 11.65.
October results set the next test
Johnson & Johnson is scheduled to report third-quarter 2026 results before the market opens on October 13, 2026. MarketBeat cites consensus estimates of USD 2.75 earnings per share and USD 25.3563 billion in revenue for the quarter. The comparison will show whether oncology growth can continue to offset pressure from older medicines and whether MedTech can close its recent gap to expectations.
Euro quote stays above prior close
The Lang & Schwarz quote stood at EUR 226.08 on October 6, 2026 at 1:02 p.m. CEST, a gain of 0.31 percent versus the EUR 225.38 prior close dated October 5, 2026. On the NYSE, the stock's primary listing, the reported 52-week range was USD 182.94 to USD 281.07 on October 6, 2026, while market capitalization was USD 609.5 billion as of October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Johnson & Johnson stock.
Johnson & Johnson stock facts
- Company: Johnson & Johnson
- ISIN: US4781601046
- Ticker: JNJ
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 6, 2026, 1:02 p.m. CEST: EUR 226.08
- Change versus prior close: plus 0.31 percent
- Prior close Lang & Schwarz October 5, 2026: EUR 225.38
- Market capitalization: USD 609.5 billion as of October 5, 2026
- Sector / Industry: Healthcare / Drug Manufacturers - General
- Next earnings date: October 13, 2026
